newsfilter
← Latest News
GlobeNewswire·

Diffusion Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update

Completed Dosing in Altitude Trial; Topline Data Expected in June 2022 Blinded, Interim Data to be Presented at UHMS Annual Scientific Meeting in May 2022 Ended Quarter with $32.6 Million in Cash, Cash Equivalents and Marketable Securities Regained C